Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients

Journal of Human Hypertension

Volumn 15, Issue , 2001, Pages S47-S51

  O'Brien E ^a   McInnes, G T ^b   Stanton, A ^a   Thom, S ^c   Caulfield, M ^d   Atkins, N ^a   Nichol, F M ^b  

^a BEAUMONT HOSPITAL   (Ireland)

^b WESTERN INFIRMARY   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Abpm; Ascot; Conventional blood pressure; Outcome

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METHODOLOGY; OUTCOMES RESEARCH; PREDICTION; RANDOMIZATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; MULTICENTER STUDIES; REGRESSION ANALYSIS;

EID: 0034794685     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001076     Document Type: Article

References (66)

1. O’Brien E, Atkins N, Staessen J. State of the market: a review of ambulatory blood pressure monitoring devices. Hypertension 1995; 26: 835-842.
2. Atkins N, O’Brien E. DABL97—A computer program for the assessment of blood pressure, risk factors and cardiovascular target organ involvement in hypertension. J Hypertens 1998; (Suppl 2): S198.
3. MacMahon S et al. Blood pressure stroke and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
4. James GD et al. The reproducibility of average ambulatory, home, and clinic pressure. Hypertension 1988; 11: 545-549.
5. Truzzi S et al. Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens 1991; 9: 115-119.
6. Asmar RG et al. Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 1988; 61: 1066-1077.
7. Cox JP, O’Malley K, Atkins N, O’Brien E. A comparison of the twenty-four-hour blood pressure profile in normotensive and hypertensive subjects. J Hypertens 1991; (Suppl 1): S3-S6.
8. Devereux RB et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983; 69: 470-476.
9. Drayer JIM, Weber MA, De Young JL. BP as a determinant of cardiac left ventricular mass. Arch Intern Med 1983; 143: 90-92.
10. Giaconi S et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989; 2: 259-261.
11. Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring: use in hypertension research and clinical practice. Hypertension 1993; 21: 510-524.
12. Opsahl JA, Abraham PA, Haltenson CE, Keane WF. Correlations of office and ambulatory blood pressure measurements with urinary albumin and N-acetylbeta-D-glucosamidase excretion in essential hypertension. Am J Hypertens 1988; 1: 117S-120S.
13. Parati G et al. Relationship of 24-hour mean and variability to target organ damage in hypertension. J Hypertens 1987; 5: 93-98.
14. Prisant LM, Carr AA, Wilson B, Converse S. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass. Am J Hypertens 1990; 3: 81-89.
15. Shimada K, Kawamoto A, Mutsubayaski K, Osaka T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990; 11: 692-699.
16. Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable records and severity of complications in essential hypertension. Circulation 1966; 34: 279-298.
17. White WB, Schulman P, Dey JM, Katz AM. Effects of age and 24-hour ambulatory blood pressure on rapid left ventricular filling. Am J Cardiol 1989; 63: 1343-1347.
18. Frattola A et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-1137.
19. Mancia G et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatmentinduced regression of left ventricular hypertrophy. Circulation 1997; 95: 1464-1470.
20. Mann S, Millar CMW, Raftery EB. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens A 1985; 7: 279-281.
21. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA 1983; 249: 2792-2798.
22. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989; (Suppl 3): S3-S10.
23. Verdecchia P et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
24. Staessen J et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patirents with systolic hypertension. JAMA 1999; 282: 539-546.
25. Fagard R, Staessen J, Thijs L, Amery A. Multiple standardised clinic blood pressure may predict left ventricular mass as well as ambulatory monitoring: a meta-analysis of comparative studies. Am J Hypertens 1995; 8: 533-540.
26. Fagard RH, Staessen JA, Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997; 29: 22-29.
27. Bianchi S et al. Diurnal variation of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1995; 8: 11670-1166.
28. Kobrin I, Oigman W, Kumar A. Diurnal variation of blood pressure in elderly patients with essential hypertension. J Am Geriatr Soc 1984; 32: 896-899.
29. Kuwajima I et al. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992; 67: 1307-1311.
30. Rizzoni D et al. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992; 5: 180-186.
31. Schillaci G et al. Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. Hypertension 1996; 28: 284-289.
32. Suzuki Y et al. The cardiac functional reserve in elderly hypertensive patients with abnormal diurnal changes in blood pressure. J Hypertens 1992; 10: 173-179.
33. Verdecchia P et al. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J Hypertens 1992; 10: 687-692.
34. Verdecchia P et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation 1993; 88: 986-992.
35. Verdecchia P et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
36. Zweiker R et al. “Non-dipping” related to cardiovascular events in essential hypertensive patients. Acta Medica Austrica 1994; 21: 86-89.
37. Roman MJ et al. Is the absence of a normal nocturnal fall in blood pressure (non-dipping) associated with cardiovascular target organ damage? J Hypertens 1997; 15: 969-978.
38. Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and non dippers. Circulation 1990; 81: 700-702.
39. Palatini P et al. Clinical relevance of night-time blood pressure and daytime blood pressure variability. Arch Intern Med 1992; 152: 1855-1860.
40. White WB, Schulman P, McCabe EJ, Day HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873-877.
41. Cheung AG, Gasster JL, Weber MA. Assessing duration of antihypertensive effect with whole-day blood pressure monitoring. Arch Intern Med 1989; 149: 2021-2025.
42. Fagard R et al. Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure. Am J Hypertens 1993; 6: 648-653.
43. Gosse P, Promax A, Durandet P, Clementy J. White coat hypertension: no harm for the heart. Hypertension 1993; 22: 766-770.
44. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993; 22: 826-831.
45. Verdecchia P et al. Prognostic significance of white coat effect. Hypertension 1997; 29: 1218-1224.
46. Conway J, Coats A, Radaelli A. Ambulatory blood pressure in relation to drug treatment and clinical trials. J Hypertens 1990; (Suppl 6): S83-S85.
47. Staessen JA et al. Ambulatory blood pressure monitoring in clinical trials. J Hypertens 1991; (Suppl 1): S13-S19.
48. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens 1989; (Suppl 3): S29-S32.
49. Mandal AK, Miller WG, Sakhayen MG, Markert RJ. Comparison of manual versus automated blood pressure measurements in treated hypertensive patients. Am J Med Sci 1997; 314: 185-189.
50. Morgan T, Anderson A, Jones E. The effect of h blood pressure control of an angiotensin converting enzyme inhibitor (peridopril) administered in the morning or at night. J Hypertens 1997; 15: 205-211.
51. Murdoch D, Heel RC. Amlodipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 1991; 41: 478-505.
52. Todd PA, Fitton A. Perindopril: a review of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991; 42: 9-114.
53. Muller JE et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987; 75: 131-138.
54. Myers A. Dewar HA. Circumstances attending deaths from coronary artery disease with coroner’s necropsies. Br Heart J 1975; 317: 1133-1143.
55. Purcell H, Mulcahy D, Fox K. Circadian patterns of myocardial ischaemia and the effects of antianginal drugs. Chronobiol Int 1991; 8: 309-320.
56. Floras JS et al. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988; 11: 273-281.
57. McLeay R, Stallard TJ, Watson RDS, Littler WD. The effect of nifedipine in arterial pressure and reflex cardiac control. Circulation 1983; 67: 1084-1089.
58. Mancia G et al. Evaluation of antihypertensive effect of once-a-day captopril by 24-hour ambulatory blood pressure monitoring. J Hypertens 1987; (Suppl 5): S591-S593.
59. Clement DL, DeBuzzeri M, Duprez DD. Influence of drugs on blood pressure variability. J Hypertens 1994; (Suppl 8): S49-S53.
60. O’Brien E, O’Malley K, Cox J, Stanton A. Ambulatory blood pressure monitoring in the evaluation of drug efficacy. Am Heart J 1991; 121: 999-1006.
61. Tochicubo O et al. Blood pressure during sleep: antihypertensive medication. Am J Cardiol 1991; 67: 18B-25B.
62. Floras JS. Antihypertensive treatment, myocardial infraction, and nocturnal myocardial ischaemia. Lancet 1988; 2: 994-996.
63. Kario K et al. Relationship between nocturnal fall in blood pressure and silent cerebrovascular damage in elderly hypertensives: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
64. Strandgaard S, Banboon OB. Cerebrovascular consequences of hypertension. Lancet 1994; 344: 519-521.
65. Neutal JM et al. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 1993; 94: 181-187.
66. Whelton A et al. Once-daily lisinopril compared with twice daily captopril on the treatment of mild to moderate hypertension: assessment of office and ambulatory blood pressure. J Clin Pharmacol 1990; 30: 1074-1080.